This article was written by Follow Bret Jensen has over 13 years as a market analyst, helping investors find big winners in the biotech sector. Bret specializes in high beta sectors with potentially large investor returns. Bret leads the investing […]
Investors Seem Content To Chase ‘Fool’s Gold’ Read More »
Lantheus Holdings: One Blockbuster, Evolving Pipeline Source link Bret Jensen
Lantheus Holdings: One Blockbuster, Evolving Pipeline Read More »
Inspire Medical Systems: Fine Company, Stretched Valuations And Slowing Growth Source link Bret Jensen
Inspire Medical Systems: Fine Company, Stretched Valuations And Slowing Growth Read More »
Collegium Pharmaceutical: Checking The Boxes Source link Bret Jensen
Collegium Pharmaceutical: Checking The Boxes Read More »
The Canary In The Coal Mine Source link Bret Jensen
The Canary In The Coal Mine Read More »
Cytokinetics: On The Cusp Of Commercialization Source link Bret Jensen
Cytokinetics: On The Cusp Of Commercialization Read More »
This article was written by Follow Bret Jensen has over 13 years as a market analyst, helping investors find big winners in the biotech sector. Bret specializes in high beta sectors with potentially large investor returns. Bret leads the investing
Apple: Investors Betting That ‘Things Are Different This Time’ (NASDAQ:AAPL) Read More »
This article was written by Follow Bret Jensen has over 13 years as a market analyst, helping investors find big winners in the biotech sector. Bret specializes in high beta sectors with potentially large investor returns. Bret leads the investing
SPY: 5 Charts Show How Overvalued The Market Has Become (NYSEARCA:SPY) Read More »
Zynex, Inc.: 2025 Looks Like A Brighter Year Source link Bret Jensen
Zynex, Inc.: 2025 Looks Like A Brighter Year Read More »
3 Predictions For The Fourth Quarter Source link Bret Jensen
3 Predictions For The Fourth Quarter Read More »
